Willfact

Willfact is a human von Willebrand factor concentrate for intravenous use, designed to support patients with von Willebrand disease. It replaces missing clotting factors to aid in bleeding control. This product is manufactured in the EU and intended for prescription use only.

Human von Willebrand factor is used to treat and prevent bleeding episodes in patients with von Willebrand disease, a condition that affects blood clotting. It may also be used before medical procedures to reduce bleeding risk. This treatment helps restore normal clotting function by replacing the missing or defective protein.

After administration, the von Willebrand factor works to help the blood clot properly, reducing the likelihood of prolonged bleeding. Patients may notice improved clotting ability within a short time following infusion. Regular use helps manage chronic bleeding tendencies associated with the condition.

Store Willfact as directed, typically refrigerated but not frozen, and protect from light. Always handle with care to avoid contamination. Use only as prescribed by a healthcare provider, and report any unusual reactions immediately. Keep out of reach of children and pets.

Certain medications, such as hormonal therapies or other clotting agents, may interact with von Willebrand factor. Alcohol and some dietary supplements could also affect how the treatment works. Always inform your healthcare provider about all medications and supplements you are taking before starting this treatment.